Silence Therapeutics Plc (SLN)
5.00
+0.14
(+2.88%)
USD |
NASDAQ |
Feb 19, 16:00
4.99
-0.01
(-0.20%)
Pre-Market: 20:00
Silence Therapeutics EPS Diluted (Quarterly) : -0.4409 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | -0.2954 |
| Mereo BioPharma Group Plc | -0.0436 |
| Bicycle Therapeutics Plc | -0.8474 |
| Akari Therapeutics Plc | -0.1948 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.83M |
| Revenue (Quarterly) | 0.158M |
| Total Expenses (Quarterly) | 20.99M |
| Enterprise Value | 134.16M |
| Gross Profit Margin (Quarterly) | -12.91% |
| Profit Margin (Quarterly) | -13.18K% |
| Earnings Yield | -47.59% |
| Normalized Earnings Yield | -47.20 |